TRIB
Trinity Biotech
TRIB
TRIB
45 hedge funds and large institutions have $72.9M invested in Trinity Biotech in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $78.4M → $72.9M (-$5.56M)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$523K | |
| 2 | +$434K | |
| 3 | +$284K | |
| 4 |
FM
Fondren Management
Houston,
Texas
|
+$175K |
| 5 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
+$150K |
Top Sellers
| 1 | -$2.18M | |
| 2 | -$1.55M | |
| 3 | -$923K | |
| 4 |
CSC
Cove Street Capital
El Segundo,
California
|
-$473K |
| 5 |
TA
Teton Advisors
Rye,
New York
|
-$78.4K |